The Illinois Wellness Insider
SEE OTHER BRANDS

Informing on health and wellness news in Illinois

The Illinois Wellness Insider: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.

Press releases published on July 22, 2025

Journey Forward Advances Neurological Rehabilitation with Power Plate® Technology

Journey Forward Advances Neurological Rehabilitation with Power Plate® Technology

CHICAGO, IL, UNITED STATES, July 22, 2025 /⁨EINPresswire.com⁩/ -- What began as a life-changing moment on a lake in 2000 has evolved into a nationally recognized model of neurological rehabilitation. After sustaining a spinal cord injury (SCI) at age 19, …

XORTX Completes Non-Brokered Private Placement of Units

XORTX Completes Non-Brokered Private Placement of Units

Not For Distribution to United States News Wire Services or for Dissemination in the United States CALGARY, Alberta, July 22, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late- …

Pennant Announces Second Quarter 2025 Earnings Release and Call

Pennant Announces Second Quarter 2025 Earnings Release and Call

EAGLE, Idaho, July 22, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its second quarter …

Kavi Global Proudly Announces SOC 2 Compliance for Kavi India, Strengthening Client Trust & Security.

Kavi Global Proudly Announces SOC 2 Compliance for Kavi India, Strengthening Client Trust & Security.

With SOC 2 Type II certification, Kavi India ensures stronger data governance for clients in healthcare, manufacturing, and transport. BARRINGTON, IL, UNITED STATES, July 22, 2025 /⁨EINPresswire.com⁩/ -- Kavi Global is proud to announce that its India …

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

MOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be covered by UnitedHealthcare across all lines of business, including …

Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences

Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences

VICTORIA, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …

Dr. Speron’s Natural Skin Care, LLC Examines Popular Skincare Ingredients and Their Effectiveness

Dr. Speron’s Natural Skin Care, LLC Examines Popular Skincare Ingredients and Their Effectiveness

Dr. Speron’s Natural Skin Care, LLC Examines Popular Skincare Ingredients and Their Effectiveness CHICAGO, IL, UNITED STATES, July 22, 2025 /⁨EINPresswire.com⁩/ -- With the skincare industry flooded with trendy ingredients and miracle claims, it’s easy …

Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025

Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025

ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …

DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer

DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer

Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, today …

DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines

DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines

Châtillon, France, le 22 juillet (22 :30 CEST) 2025 DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— CUSIP: 23306J309), …

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 first quarter results at 9:00 a.m. ET on August 7, 2025. The conference …

Seer to Report Second Quarter 2025 Financial Results on August 6, 2025

Seer to Report Second Quarter 2025 Financial Results on August 6, 2025

REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday, August …

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis 

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis 

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis   50 mg once-daily dose of obefazimod led to a …

Amwell® to report second quarter 2025 operating results;  company leaders to attend upcoming investor conferences

Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on …

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025

WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to …

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

CANTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Sanuwave Health to Present at Canaccord Genuity Growth Conference

Sanuwave Health to Present at Canaccord Genuity Growth Conference

EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Frank, Chief Executive Officer, will present at the 45th …

Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025

Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025

SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it …

Jushi Holdings Inc. to Report Second Quarter 2025 Financial Results on August 5, 2025

Jushi Holdings Inc. to Report Second Quarter 2025 Financial Results on August 5, 2025

BOCA RATON, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the second …

Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025

Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025

ALACHUA, Fla. and TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will report …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service